Information Provided By:
Fly News Breaks for April 25, 2018
ILMN
Apr 25, 2018 | 05:02 EDT
Illumina reported 31% revenue growth to $782M in Q1, well above the Street's $744M estimate on broad consumables and services strength, despite sequencing instruments coming in light, Piper Jaffray analyst William Quirk tells investors in a research note. The analyst remains convinced that there are a number of positive, long-term tailwinds for sequencing. He raised his price target for Illumina shares to $272 from $269 and reiterates an Overweight rating on the name.
News For ILMN From the Last 2 Days
There are no results for your query ILMN